Investing in the future Allianz X invests in digital frontrunners in ecosystems relevant to insurance and asset management. In just a few years, it has grown to a portfolio of more than 25 companies and AuM of over 1.5 billion euros. Allianz X has counted 12 unicorns among its portfolio so far. The heart and brains behind it all are a talented team of around 40 people. As one of the pillars of the Allianz Group’s digital transformation strategy, Allianz X provides an interface between Allianz Operating Entities and the broader digital ecosystem, enabling collaborative partnerships in insurtech, fintech, and …

Tags: DAX30 Sectors: Insurance

Shaping the future with Deep Tech - from Singapore, for the world. Our Mission We help entrepreneurial scientists build Deep Tech startups. Our Purpose The world has hard problems to solve, and answers are urgently needed. We help entrepreneurs on a mission to solve these hard problems, build companies. We believe Singapore has the resources and capabilities to tackle the pressing challenges impacting people around the world. SGInnovate has been established to help these ambitious and capable people to build 'technology-intensive' products borne out of scientific research, leveraging the full power of the Singapore ecosystem to achieve this mission. Venture …

Advancing the Sustainable Development Goals through education and scientific inquiry. The United Nations Academic Impact (UNAI) is an initiative that engages institutions of higher education with the United Nations in actively supporting and contributing to the realisation of UN goals and mandates including the promotion and protection of human rights, access to education, sustainability and conflict resolution. Education, Human Rights, Sustainable Development Goals, and Peace and Security

Sectors: International development

#WeareBiotech Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world …

Sectors: Biotechnology